<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04785001</url>
  </required_header>
  <id_info>
    <org_study_id>HBD_2020_23</org_study_id>
    <nct_id>NCT04785001</nct_id>
  </id_info>
  <brief_title>New Markers to Assess the Efficacity of Spinal Cord Stimulation for the Treatment of Chronic Lower Limb Pain (MOTIVE)</brief_title>
  <official_title>Assessment of New Physiological, Radiological and Activity Markers in Patients Treated by Spinal Cord Stimulation for Chronic Lower Limb Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      By combining the usual care of patients eligible for spinal cord stimulation (SME) with&#xD;
      measurements of the HRV index (Heart Rate Variability), objective measurements of activity&#xD;
      (number of steps, quality of sleep) and measurements of connectivity obtained by anatomical&#xD;
      and functional magnetic resonance imaging (fMRI), the collection of preliminary data&#xD;
      necessary for the analysis of markers correlated with the efficiency of stimulation will be&#xD;
      possible. Ultimately, these markers could be used to optimize the perioperative management of&#xD;
      these patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The rebellious chronic neuropathic pain of the lower limbs (including the sequelae&#xD;
      lumbosciatica) causes a major functional repercussion and an impairment of the quality of&#xD;
      life. Spinal cord stimulation (SCS) is offered when other treatments are ineffective or&#xD;
      insufficient (K. Kumar et al., 2007). This technique has been used in routine care for over&#xD;
      20 years, with a well-established clinical benefit for these indications, and recognized by&#xD;
      HAS (see 2014 recommendations in appendix 1). Moreover, recent technical progress has made it&#xD;
      possible to provide better user comfort for implanted patients, in particular with new&#xD;
      stimulation methods that best adapt to the activities and feelings of the patients (De Ridder&#xD;
      &amp; Vanneste, 2016; V . Kumar et al., 2018).&#xD;
&#xD;
      The therapeutic objectives defined between the candidate patient for EMS and the Pain team&#xD;
      are part of a personalized rehabilitation and reintegration process. This is to reduce the&#xD;
      pain felt by the patient but also the functional impact, by gradually resuming activity,&#xD;
      taking into account the specific situation of each patient. Functional limitation depends on&#xD;
      several factors, such as exercise deconditioning but also fear of movement that is essential&#xD;
      to assess in patients who are candidates for EMS. Patient care involves an assessment made by&#xD;
      a trained multi-professional team in which the role of the pain coordinator (IDEC) is&#xD;
      central, with therapeutic education work through regular physical and telephone&#xD;
      consultations. Self-administered questionnaires analyzing functional abilities, quality of&#xD;
      life and pain are currently being used for the pre- and post-operative assessment of patients&#xD;
      undergoing EMS. Although they are a diagnostic and decision-making tool, they nevertheless&#xD;
      correspond to a subjective assessment of the patient of his abilities as he sees them, and&#xD;
      not to an assessment of his actual objective abilities. Thus, despite the technical progress&#xD;
      represented by the new stimulation methods, the perioperative assessment of patients treated&#xD;
      for EMS lacks personalized tools.&#xD;
&#xD;
      The recent development of technological tools that are easy to use on a daily basis, such as&#xD;
      activity trackers and smartwatches, is an attractive option in chronic pathologies, but still&#xD;
      insufficiently used in current medical practice. A review of the literature has shown the&#xD;
      value of the use of activity trackers, particularly in postoperative follow-up and functional&#xD;
      rehabilitation (Appelboom et al., 2016), and in low back pain patients (GORDON &amp; BLOXHAM,&#xD;
      2017 ). Another study evaluating the data collected by an actimeter integrated into a&#xD;
      stimulation generator compared to the patient's verbal report on his activities reports an&#xD;
      overestimation of the functional impact by patients in self-evaluation (Goudman et al.,&#xD;
      2018). Likewise, a study on the evaluation of the quality of sleep highlighted a difference&#xD;
      between the feelings reported by the patient, the self-questionnaires and the data recorded&#xD;
      in polysomnography (Jaeger et al., 2019), with a trend to increase sleep disorders. All of&#xD;
      these studies confirm the limits in terms of the reliability of declarative data and the need&#xD;
      for objective measures to assess the symptoms of patients in chronic conditions.&#xD;
&#xD;
      In addition, some of these devices have recently made it possible to evaluate the vmHRV&#xD;
      (vagally-mediated Heart Rate Variability) index (Hernando et al., 2018). This physiological&#xD;
      index has been studied for MOTIVE_Protocole_v1_20200610 HBD_2020_23 IDRCB 2020-A01731-38&#xD;
      11/40 several years, and has shown its interest in various chronic pathologies such as&#xD;
      depression, cardiovascular pathologies, fibromyalgia (Kemp et al., 2010). Thus, compared to&#xD;
      healthy control subjects, patients with chronic pain have a decreased vmHRV index linked to&#xD;
      lower vagal activity (Koenig et al., 2016). In addition, in chronic pain patients, a&#xD;
      correlation was observed between taking analgesics, the impact of pain on daily life and a&#xD;
      significantly reduced vmHRV index. Moreover, patients with little relief from drug treatment&#xD;
      had the lowest vmHRV index (Koenig et al., 2015), thus showing a link between this index and&#xD;
      the severity of chronic pain, its daily impact, l effectiveness of drug treatment. Likewise,&#xD;
      a correlation has been demonstrated between the degree of catastrophization of pain in&#xD;
      patients and the vmHRV index (Koenig et al., 2016). Finally, a recent review of the imaging&#xD;
      data associated with the measurement of the HRV index suggests a link between functional&#xD;
      connectivity and the activity of certain brain regions (ventral striatum, anterior cingulate&#xD;
      cortex, medial pre-frontal cortex, putamen ), the ability to manage stress and emotions, and&#xD;
      the HRV index (Thayer et al., 2012), thus proposing a neurovisceral integration model. The&#xD;
      vmHRV index can therefore be considered as an objective marker in the assessment of emotional&#xD;
      and physiological coping skills in a patient with chronic pain. This aspect is crucial in the&#xD;
      evaluation and management of these patients, and more particularly when an invasive therapy&#xD;
      is envisaged such as EMS.&#xD;
&#xD;
      Finally, the development of certain imaging sequences makes it possible to study the&#xD;
      anatomical (diffusion tensor sequences: DTI) and functional (functional MRI sequences)&#xD;
      connectivity in regions of interest in patients, in particular at rest (Fox &amp; Raichle, 2007).&#xD;
      During nociceptive stimulation, the functional activation of certain regions of interest was&#xD;
      demonstrated, grouped together under the term &quot;pain matrix&quot;: insula, primary and secondary&#xD;
      somatosensory cortex, thalamus, anterior cingulate cortex, pre- frontal, tonsil and&#xD;
      peri-acqueductal gray matter (Apkarian et al., 2005; Leknes &amp; Tracey, 2008). Chronic pain&#xD;
      alters the functioning of neural circuits in these regions, leading to changes in&#xD;
      connectivity and activity observable in neuroimaging (Baliki et al., 2012; Wood et al.,&#xD;
      2007). A prospective study conducted in 39 patients has also shown the predictive character&#xD;
      of some of these changes during the chronicization of pain in a cohort of patients suffering&#xD;
      from subacute low back pain (Baliki et al., 2012): patients developing pain patients (which&#xD;
      lasts beyond 6 months) immediately presented an alteration in the functioning of the neural&#xD;
      circuits involved in motivation, with a stronger anatomical and functional connectivity&#xD;
      between the nucleus accumbens and the medial pre-frontal cortex, compared to the patients&#xD;
      recovering from the subacute episode. Since then, other studies have suggested a link between&#xD;
      the process of pain chronicization and changes in the anatomical and functional connectivity&#xD;
      of cortico-striated circuits involved in cognitive and motivational aspects (Navratilova &amp;&#xD;
      Porreca, 2014). Activation of the meso-limbic motivational and reward circuit has also been&#xD;
      shown to be involved in the perception of pain relief (Leknes et al., 2011; Navratilova et&#xD;
      al., 2012; Seymour et al., 2005) .&#xD;
&#xD;
      The interest of these new cardiac markers (HRV), radiological (anatomical and functional&#xD;
      connectivity in MRI) and activity (connected watch) in the management of patients eligible&#xD;
      for stimulation medullary will be evaluate. The use of a connected watch continuously&#xD;
      measuring activity (number of steps, distance covered), sleep (duration of deep and light&#xD;
      sleep, number of nocturnal awakenings), and the HRV index could provide an objective&#xD;
      assessment and complementary to the self-questionnaires and the usual interviews. The MRI&#xD;
      profile of anatomical and functional connectivity in the regions of interest linked to&#xD;
      chronic pain and motivation in patients treated for EMS, would allow to seek a link between&#xD;
      functional outcome, motivation and the ability to adapt and manage stress.&#xD;
&#xD;
      By combining the usual care of patients eligible for an EMS with measurements of the HRV&#xD;
      index, objective measurements of activity (number of steps, quality of sleep), and&#xD;
      connectivity measurements obtained on MRI, the collection of preliminary data to identify&#xD;
      markers correlated with the effectiveness of EMS will be possible. Ultimately, these markers&#xD;
      could be used to optimize the perioperative management of these patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 6, 2021</start_date>
  <completion_date type="Anticipated">June 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of Heart Rate Variability (HRV) in chronic lower leg pain patients treated with spinal cord stimulation.</measure>
    <time_frame>3 months after implantation</time_frame>
    <description>Heart rate variability will be evaluated before (baseline) and 3 months after surgery. HRV parameters, including time domain and frequency domain, will be obtained from 24-hour Holter monitoring. Two time-domain variables will be used to determine HRV : the standard deviation of intervals of all normal beat (SDNN) and the root mean square of the difference of successive R-R intervals (rMSSD).</description>
  </primary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Spinal Cord Stimulation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients followed for drug-resistant neuropathic pain in the lower limbs and requiring&#xD;
        implantation for SCS according to HAS criteria will be eligible.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Lower limb pain included in the inclusion criteria for spinal cord stimulation&#xD;
             according to HAS recommendations: neuropathic, lumbar radicular sequelae after spinal&#xD;
             surgery, complex regional pain syndrome (CRPS)&#xD;
&#xD;
          -  Chronic pain that has been present for at least 6 months&#xD;
&#xD;
          -  Rebellious pain resistant to drug and non-drug treatments well conducted;&#xD;
&#xD;
          -  Functional impact defined by a score&gt; 20% on the Oswestry scale;&#xD;
&#xD;
          -  Patient affiliated or beneficiary of a social security scheme;&#xD;
&#xD;
          -  Patient who consented to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of a surgical contraindication to the implantation of material (chronic&#xD;
             infection, long-term anticoagulant treatment that cannot be interrupted,&#xD;
             contraindication to anesthesia);&#xD;
&#xD;
          -  Addiction (according to DSM IV);&#xD;
&#xD;
          -  Major depressive syndrome despite appropriate treatment and / or psychotic symptoms&#xD;
             (according to DSM IV);&#xD;
&#xD;
          -  Unbalanced psychiatric disorder;&#xD;
&#xD;
          -  Intermittent pain or present for less than 6 months;&#xD;
&#xD;
          -  Diffuse painful syndrome;&#xD;
&#xD;
          -  Progressive disease, associated inflammatory rheumatic pathology, and any other&#xD;
             disabling pathology limiting physical activity (advanced articular osteoarthritis);&#xD;
&#xD;
          -  Absolute contraindication to MRI (e.g. pace-maker, implantable stimulator,&#xD;
             intra-orbital metallic foreign body);&#xD;
&#xD;
          -  Language barrier or cognitive disorders preventing understanding of the research&#xD;
             protocol;&#xD;
&#xD;
          -  Person benefiting from a legal protection measure;&#xD;
&#xD;
          -  Pregnant or breastfeeding woman.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hayat BELAID, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondation Ophtalmologie Adolphe Rothschild</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Am√©lie YAVCHITZ, Dr</last_name>
    <phone>01 48 03 64 54</phone>
    <email>ayavchitz@for.paris</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondation Ophtalmologie Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>March 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>August 12, 2021</last_update_submitted>
  <last_update_submitted_qc>August 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SCS (spinal cord stimulation)</keyword>
  <keyword>HRV (Heart Rate Variability)</keyword>
  <keyword>MRIf (anatomical and functional magnetic resonance imaging)</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

